State of New Jersey Common Pension Fund D’s Travere Therapeutics TVTX Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.52M	Sell	26,843 -2,206	-8%	-$97.8K	0.01%	1246
2026 Q1	$863K	Buy	29,049 +145	+0.5%	+$4.33K	﹤0.01%	1414
2025 Q4	$1.1M	Buy	+28,904	New	+$940K	﹤0.01%	1391
2023 Q4	–	Sell	-189,415	Closed	-$1.69M	–	1609
2023 Q3	$1.69M	Buy	+189,415	New	+$2.67M	0.01%	1556
2022 Q4	–	Sell	-86,045	Closed	-$2.12M	–	1742
2022 Q3	$2.12M	Buy	+86,045	New	+$2.22M	0.01%	1232
2021 Q2	–	Sell	-82,981	Closed	-$2.07M	–	1877
2021 Q1	$2.07M	Buy	+82,981	New	+$2.29M	0.01%	1537
2020 Q3	–	Sell	-120,514	Closed	-$2.46M	–	1642
2020 Q2	$2.46M	Buy	+120,514	New	+$1.92M	0.01%	1049
2019 Q4	–	Sell	-106,700	Closed	-$1.24M	–	1656
2019 Q3	$1.24M	Buy	+106,700	New	+$1.76M	﹤0.01%	1531

Other funds holding TVTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

State of New Jersey Common Pension Fund D's TVTX Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Travere Therapeutics (TVTX) stake by 7.6% in Q2 2026, selling an estimated $97.8K and leaving 26,843 shares worth $1.52M. The position accounts for 0.01% of the portfolio, ranked #1246.

State of New Jersey Common Pension Fund D first reported a position in TVTX in Q3 2019 and has held it in 8 quarters since. The position peaked at $2.46M in Q2 2020. 130 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

State of New Jersey Common Pension Fund D held 26,843 shares of Travere Therapeutics worth $1.52M as of Q2 2026.
State of New Jersey Common Pension Fund D sold 2,206 Travere Therapeutics shares in Q2 2026, an estimated $97.8K.
Travere Therapeutics made up 0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1246 holding.
State of New Jersey Common Pension Fund D first reported a position in Travere Therapeutics in Q3 2019 and has held it in 8 quarters since.
State of New Jersey Common Pension Fund D's Travere Therapeutics position peaked at $2.46M in Q2 2020.
130 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.